Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Zyban (Bupropion Hydrochloride) Sustained-Release Tablet
Company:  Glaxo Wellcome, Inc.
Application No.:  020711s002/s004
Approval Date: 02/24/1999


Date created: May 15, 2006

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.